Author

Ivan Kodvanj

PROTON PUMP INHIBITORS USE IS NOT ASSOCIATED WITH THE RISK OF COVID-19-RELATED MORTALITY OR HOSPITALIZATION: CROATIAN NATIONWIDE COHORT STUDY
PROTON PUMP INHIBITORS USE IS NOT ASSOCIATED WITH THE RISK OF COVID-19-RELATED MORTALITY OR HOSPITALIZATION: CROATIAN NATIONWIDE COHORT STUDY

Ivan Kodvanj  et al.

INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH AN INCREASED RISK FOR COVID-19-RELATED HOSPITALIZATION, BUT NOT WITH MORTALITY: CROATIAN NATIONWIDE COHORT STUDY
INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH AN INCREASED RISK FOR COVID-19-RELATED HOSPITALIZATION, BUT NOT WITH MORTALITY: CROATIAN NATIONWIDE COHORT STUDY

PROTON PUMP INHIBITORS USE IS NOT ASSOCIATED WITH THE RISK OF COVID-19-RELATED MORTALITY OR HOSPITALIZATION: CROATIAN NATIONWIDE COHORT STUDY
PROTON PUMP INHIBITORS USE IS NOT ASSOCIATED WITH THE RISK OF COVID-19-RELATED MORTALITY OR HOSPITALIZATION: CROATIAN NATIONWIDE COHORT STUDY

INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH AN INCREASED RISK FOR COVID-19-RELATED HOSPITALIZATION, BUT NOT WITH MORTALITY: CROATIAN NATIONWIDE COHORT STUDY
INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH AN INCREASED RISK FOR COVID-19-RELATED HOSPITALIZATION, BUT NOT WITH MORTALITY: CROATIAN NATIONWIDE COHORT STUDY

Ivan Kodvanj  et al.

Item 1 - 4 / 4
1